The global dyspnea treatment market was valued at US$ 6.16 billion in 2023 and is expected to reach US$ 11.01 billion by 2032, growing at a CAGR of 6.95% from 2024 to 2032. Some reports project the market to reach US$ 18.27 billion by 2034, with a CAGR of around 6.08% from 2025 to 2034